These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1685338)

  • 1. Changes in the positive and negative symptoms of schizophrenic in-patients in China.
    Phillips MR; Zhao ZA; Xiong XZ; Cheng XF; Sun GR; Wu NS
    Br J Psychiatry; 1991 Aug; 159():226-31. PubMed ID: 1685338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delay to first antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness.
    Haas GL; Garratt LS; Sweeney JA
    J Psychiatr Res; 1998; 32(3-4):151-9. PubMed ID: 9793868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiating primary from secondary negative symptoms in schizophrenia: a study of neuroleptic-naive patients before and after treatment.
    Peralta V; Cuesta MJ; Martinez-Larrea A; Serrano JF
    Am J Psychiatry; 2000 Sep; 157(9):1461-6. PubMed ID: 10964863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of an open-door policy combined with a structured activity programme on the residual symptoms of schizophrenic in-patients. A six-month randomised controlled trial in Yanbian, Jilin.
    Jin Z
    Br J Psychiatry Suppl; 1994 Aug; (24):52-7. PubMed ID: 7946232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptoms at index admission as predictor for 1-5 year outcome in schizophrenia.
    Wieselgren IM; Lindström E; Lindström LH
    Acta Psychiatr Scand; 1996 Nov; 94(5):311-9. PubMed ID: 9124077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative symptoms at discharge and outcome in schizophrenia.
    Hwu HG; Tan H; Chen CC; Yeh LL
    Br J Psychiatry; 1995 Jan; 166(1):61-7. PubMed ID: 7894878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients.
    Szymanski S; Lieberman JA; Alvir JM; Mayerhoff D; Loebel A; Geisler S; Chakos M; Koreen A; Jody D; Kane J
    Am J Psychiatry; 1995 May; 152(5):698-703. PubMed ID: 7726309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A behavioural training programme for chronic schizophrenic patients. A three-month randomised controlled trial in Beijing.
    Li F; Wang M
    Br J Psychiatry Suppl; 1994 Aug; (24):32-7. PubMed ID: 7946229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic dose and schizophrenic symptoms. A survey of prescribing practices.
    Peralta V; Cuesta MJ; Caro F; Martinez-Larrea A
    Acta Psychiatr Scand; 1994 Nov; 90(5):354-7. PubMed ID: 7872040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erotomanic symptoms in 42 Chinese schizophrenic patients.
    Phillips MR; West CL; Wang R
    Br J Psychiatry; 1996 Oct; 169(4):501-8. PubMed ID: 8894203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and predictive values of first rank symptoms at baseline among 362 young adult patients with first-episode schizophrenia Results from the Danish OPUS study.
    Thorup A; Petersen L; Jeppesen P; Nordentoft M
    Schizophr Res; 2007 Dec; 97(1-3):60-7. PubMed ID: 17698323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Course of treatment response in first-episode and chronic schizophrenia.
    Szymanski SR; Cannon TD; Gallacher F; Erwin RJ; Gur RE
    Am J Psychiatry; 1996 Apr; 153(4):519-25. PubMed ID: 8599400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.
    Kopala LC; Fredrikson D; Good KP; Honer WG
    Biol Psychiatry; 1996 Feb; 39(4):296-8. PubMed ID: 8645777
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evolution of the social autonomy scale (EAS) in schizophrenic patients depending on their management].
    Leguay D; Rouillon F; Azorin JM; Gasquet I; Loze JY; Arnaud R; Dillenschneider A
    Encephale; 2010 Oct; 36(5):397-407. PubMed ID: 21035630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Follow-up dynamics of schizophrenic diseases in adolescence].
    Schulz E; Martin M; Remschmidt H
    Z Kinder Jugendpsychiatr; 1994 Dec; 22(4):262-74. PubMed ID: 7856322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An international perspective on assessment of negative and positive symptoms in schizophrenia.
    Moscarelli M; Maffei C; Cesana BM; Boato P; Farma T; Grilli A; Lingiardi V; Cazzullo CL
    Am J Psychiatry; 1987 Dec; 144(12):1595-8. PubMed ID: 3688286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rehabilitative effect of music therapy for residual schizophrenia. A one-month randomised controlled trial in Shanghai.
    Tang W; Yao X; Zheng Z
    Br J Psychiatry Suppl; 1994 Aug; (24):38-44. PubMed ID: 7946230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six-month clinical status as a predictor of 24-month clinical outcome in first-admission patients with schizophrenia.
    Craig T; Fennig S; Tanenberg-Karant M; Bromet EJ
    Ann Clin Psychiatry; 1999 Dec; 11(4):197-203. PubMed ID: 10596734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficit syndromes in schizophrenic patients 15 years after their first hospitalisation: preliminary results of a follow-up study.
    Bottlender R; Wegner U; Wittmann J; Strauss A; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 4():27-36. PubMed ID: 10654106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptom classification of schizophrenia changes with the duration of illness.
    Hori A; Tsunashima K; Watanabe K; Takekawa Y; Ishihara I; Terada T; Uno M
    Acta Psychiatr Scand; 1999 Jun; 99(6):447-52. PubMed ID: 10408267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.